Allocation of COVID-19 Vaccines Under Limited Supply
Chen, X.; Li, M.; Simchi-Levi, D.; Zhao, T.
Show abstract
Problem definitionThis paper considers how to allocate COVID-19 vaccines to different age groups when limited vaccines are available over time. Academic/practical relevanceVaccine is one of the most effective interventions to contain the ongoing COVID-19 pandemic. However, the initial supply of the COVID-19 vaccine will be limited. An urgent problem for the government is to determine who to get the first dose of the future COVID-19 vaccine. MethodologyWe use epidemic data from New York City to calibrate an age-structured SAPHIRE model that captures the disease dynamics within and across various age groups. The model and data allow us to derive effective static and dynamic vaccine allocation policies minimizing the number of confirmed cases or the numbers of deaths. ResultsThe optimal static policies achieve a much smaller number of confirmed cases and deaths compared to other static benchmark policies including the pro rata policy. Dynamic allocation policies, including various versions of the myopic policy, significantly improve on static policies. Managerial implicationsFor static policies, our numerical study shows that prioritizing the older groups is beneficial to reduce deaths while prioritizing younger groups is beneficial to avert infections. For dynamic policies, the older groups should be vaccinated at early days and then switch to younger groups. Our analysis provides insights on how to allocate vaccines to the various age groups, which is tightly connected to the decision-makers objective.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Resource Allocation for Different Types of Vaccines against COVID-19: Tradeoffs and Synergies between Efficacy and Reach 96%
- Value of information dynamics in Disease X vaccine clinical trials 95%
- Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response 95%
Similar papers in this journal
- Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models 97%
- Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation * 96%
- Will Vaccine-derived Protective Immunity Curtail COVID-19 Variants in the US? 95%
Similar papers in this journal
- COVID-19 Underreporting and its Impact on Vaccination Strategies 95%
- Modelling the impact of hybrid immunity on future COVID-19 epidemic waves 94%
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.